Yang Xia Selected Research

Yang Xia Research Topics

Disease

72	Neoplasms (Cancer) 03/2024 - 08/2006
37	Inflammation (Inflammations) 01/2024 - 09/2007
33	Hypoxia (Hypoxemia) 01/2024 - 01/2012
32	Pre-Eclampsia (Preeclampsia) 01/2020 - 02/2003
28	Hypertension (High Blood Pressure) 01/2022 - 08/2008
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2013
15	Fibrosis (Cirrhosis) 04/2024 - 08/2005
14	Proteinuria 01/2020 - 08/2008
13	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2014
12	Infections 05/2024 - 05/2011
12	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2008
12	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 01/2011
11	Non-alcoholic Fatty Liver Disease 04/2024 - 11/2016
10	Adenocarcinoma of Lung 10/2023 - 01/2016
9	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2013
8	Disease Progression 01/2019 - 06/2014
8	Priapism 06/2014 - 04/2008
7	Pulmonary Hypertension 01/2020 - 06/2012
6	Brain Injuries (Brain Injury) 11/2022 - 02/2013
6	Type 2 Diabetes Mellitus (MODY) 03/2019 - 08/2015
5	Pain (Aches) 05/2024 - 01/2016
5	Chronic Renal Insufficiency 05/2024 - 07/2015
5	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 09/2007
5	Carcinogenesis 01/2023 - 01/2012
5	Hemolysis 01/2018 - 08/2008
4	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 09/2016
4	Asthma (Bronchial Asthma) 01/2024 - 09/2007
4	Hyperuricemia 12/2023 - 01/2020
4	Dry Eye Syndromes (Dry Eye Syndrome) 12/2023 - 01/2023
4	Neuroblastoma 03/2023 - 09/2013
4	Epilepsy (Aura) 01/2023 - 11/2009
4	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2017
4	Esophageal Squamous Cell Carcinoma 01/2022 - 01/2014
4	Temporal Lobe Epilepsy 04/2021 - 07/2013
4	Osteoarthritis 01/2021 - 10/2015
4	AIDS-Related Complex (ARC) 03/2020 - 09/2013
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 08/2005
4	Lung Diseases (Lung Disease) 01/2019 - 08/2005
4	Wounds and Injuries (Trauma) 10/2017 - 05/2011
4	Pneumonia (Pneumonitis) 08/2013 - 08/2005
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2024 - 10/2023
3	Seizures (Absence Seizure) 01/2024 - 05/2020

Drug/Important Bio-Agent (IBA)

40	Adenosine (Adenocard)FDA LinkGeneric 10/2023 - 08/2005
24	AutoantibodiesIBA 08/2017 - 02/2003
20	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2010
18	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2008
18	MicroRNAs (MicroRNA)IBA 05/2023 - 01/2012
17	CytokinesIBA 11/2023 - 05/2010
16	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016 - 02/2003
13	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2018 - 09/2007
12	Long Noncoding RNAIBA 10/2023 - 01/2016
12	EnzymesIBA 01/2022 - 09/2007
11	Interleukin-6 (Interleukin 6)IBA 01/2020 - 05/2011
10	Angiotensin IIIBA 10/2023 - 09/2004
9	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
9	Tyrosine (L-Tyrosine)FDA Link 01/2017 - 01/2007
8	Uric Acid (Urate)IBA 05/2024 - 08/2016
8	Immunoglobulin G (IgG)IBA 08/2018 - 02/2003
8	Adenosine DeaminaseIBA 01/2017 - 08/2005
7	osthol (osthole)IBA 11/2022 - 01/2014
7	Oxygen (Dioxygen)IBA 01/2022 - 05/2013
7	Messenger RNA (mRNA)IBA 01/2022 - 03/2010
7	Adenosine A2B ReceptorIBA 01/2021 - 12/2013
6	CarbohydratesIBA 04/2024 - 11/2008
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 08/2016
6	Hemoglobins (Hemoglobin)IBA 01/2022 - 05/2013
6	Peptides (Polypeptides)IBA 10/2021 - 05/2014
6	Pilocarpine (Ocusert)FDA LinkGeneric 04/2021 - 11/2009
6	C-Reactive ProteinIBA 01/2020 - 01/2013
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 01/2010
6	Interleukin-10 (Interleukin 10)IBA 09/2016 - 02/2011
5	Equilibrative Nucleoside Transporter 1IBA 10/2023 - 01/2012
5	ORALIT (ORS)IBA 01/2023 - 01/2020
5	Therapeutic UsesIBA 01/2023 - 09/2010
5	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 01/2013
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2014
5	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2020 - 06/2014
5	CreatinineIBA 01/2019 - 05/2010
5	Immunoglobulin M (IgM)IBA 08/2018 - 01/2008
5	AntibodiesIBA 01/2016 - 09/2004
4	Tyrosine Kinase InhibitorsIBA 02/2024 - 01/2019
4	TransglutaminasesIBA 01/2024 - 02/2014
4	TeaIBA 12/2023 - 11/2019
4	RNA (Ribonucleic Acid)IBA 05/2023 - 01/2020
4	Glutathione (Reduced Glutathione)IBA 03/2022 - 10/2016
4	CateninsIBA 10/2020 - 01/2012
4	2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)IBA 01/2020 - 10/2016
4	Hyaluronic Acid (Hyaluronan)IBA 01/2019 - 12/2013
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018 - 01/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 01/2007
4	Alanine Transaminase (SGPT)IBA 09/2018 - 11/2016
4	Immunoglobulins (Immunoglobulin)IBA 08/2018 - 05/2016
4	Immunoglobulin E (IgE)IBA 08/2018 - 06/2012
4	CalcineurinIBA 04/2008 - 11/2005
3	VaccinesIBA 05/2024 - 01/2016
3	Ophthalmic Solutions (Eye Drops)IBA 12/2023 - 01/2023

Therapy/Procedure

53	Therapeutics 02/2024 - 01/2007
10	Immunotherapy 04/2024 - 01/2020
5	Drug Therapy (Chemotherapy) 11/2022 - 01/2007
5	Enzyme Therapy 12/2020 - 08/2005